688189 ST南新制药
2026/09 - 九个月
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产132,678-8.61%145,180163,557184,895200,731
在建工程4,9040.00%4,904353573240
无形资产81,362-8.45%88,872143,135124,284138,006
商誉0--0010,84510,845
其他非流动资产176,9073.64%170,689137,043126,928108,614
395,852-3.37%409,645444,089447,525458,436

流动资产
货币资金362,23920.14%301,519490,270665,761713,472
应收账款12,685-64.80%36,034195,598508,716728,193
存货30,180-15.88%35,87661,16730,36627,015
其他流动资产22,733-13.88%26,39831,31555,06327,492
427,8377.01%399,827778,3501,259,9061,496,172

流动负债
短期借款60,034498.54%10,030218,187322,950488,733
应付票据0--0000
应付帐款23,497-13.72%27,23339,59139,54837,496
其他流动负债53,624-4.68%56,25882,07565,538122,127
137,15546.66%93,521339,853428,035648,355
流动资产净值290,681-5.10%306,306438,497831,870847,817
资产总额减流动负债686,533-4.11%715,951882,5861,279,3961,306,253

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债4,88137.80%3,5424,2805,7689,881
4,88137.80%3,5424,2805,7689,881

总权益
    实收股本272,829-0.57%274,400274,400274,400196,000
    储备项目482,194-5.29%509,150662,1921,018,6971,118,365
股东权益755,024-3.64%783,550936,5921,293,0971,314,365
非控股权益(73,371)3.13%(71,141)(58,286)(19,470)(17,993)